BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological evaluation of quinoline derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors. 2016

Kun Li, and Ying Li, and Di Zhou, and Yinbo Fan, and Hongye Guo, and Tianyi Ma, and Jiachen Wen, and Dan Liu, and Linxiang Zhao
Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.

In this work, a series of quinoline derivatives were designed and synthesized as antitumor agents. Most quinolines showed potent anti-proliferative activity against human prostatic cancer PC-3 cell line. Among which, 9d, 9f and 9g were the most effective compounds with GI50 values of 2.60, 2.81 and 1.29 μM, respectively. Structure-activity relationship analysis indicated that the secondary amine linked quinoline and pyridine ring played an important role in the anti-proliferative effects. Mechanistic studies revealed that 9g was a potential Pim-1 kinase inhibitor with abilities of cell cycle arrest and apoptosis induction. Considering of the increased activity of Pim-1 in prostate cancer, such compounds have potential to be developed as anti-prostate cancer agents.

UI MeSH Term Description Entries
D008297 Male Males
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011804 Quinolines
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Kun Li, and Ying Li, and Di Zhou, and Yinbo Fan, and Hongye Guo, and Tianyi Ma, and Jiachen Wen, and Dan Liu, and Linxiang Zhao
Synthesis of Tetrahydrobenzo[b]thiophene-3-carbohydrazide Derivatives as Potential Anti-cancer Agents and Pim-1 Kinase Inhibitors.
January 2019, Anti-cancer agents in medicinal chemistry,
Kun Li, and Ying Li, and Di Zhou, and Yinbo Fan, and Hongye Guo, and Tianyi Ma, and Jiachen Wen, and Dan Liu, and Linxiang Zhao
Synthesis and biological evaluation of arylpiperazine derivatives as potential anti-prostate cancer agents.
January 2019, Bioorganic & medicinal chemistry,
Kun Li, and Ying Li, and Di Zhou, and Yinbo Fan, and Hongye Guo, and Tianyi Ma, and Jiachen Wen, and Dan Liu, and Linxiang Zhao
New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation.
February 2021, Molecules (Basel, Switzerland),
Kun Li, and Ying Li, and Di Zhou, and Yinbo Fan, and Hongye Guo, and Tianyi Ma, and Jiachen Wen, and Dan Liu, and Linxiang Zhao
Pyridazinone derivatives as potential anti-inflammatory agents: synthesis and biological evaluation as PDE4 inhibitors.
April 2021, RSC medicinal chemistry,
Kun Li, and Ying Li, and Di Zhou, and Yinbo Fan, and Hongye Guo, and Tianyi Ma, and Jiachen Wen, and Dan Liu, and Linxiang Zhao
Synthesis and biological evaluation of Schizandrin derivatives as potential anti-cancer agents.
April 2018, European journal of medicinal chemistry,
Kun Li, and Ying Li, and Di Zhou, and Yinbo Fan, and Hongye Guo, and Tianyi Ma, and Jiachen Wen, and Dan Liu, and Linxiang Zhao
Design, synthesis and biological evaluation of new quinoline derivatives as potential antitumor agents.
September 2019, European journal of medicinal chemistry,
Kun Li, and Ying Li, and Di Zhou, and Yinbo Fan, and Hongye Guo, and Tianyi Ma, and Jiachen Wen, and Dan Liu, and Linxiang Zhao
Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents.
August 2012, European journal of medicinal chemistry,
Kun Li, and Ying Li, and Di Zhou, and Yinbo Fan, and Hongye Guo, and Tianyi Ma, and Jiachen Wen, and Dan Liu, and Linxiang Zhao
Design, Synthesis and Biological Evaluation of Thiohydantoin Derivatives as Novel Anti-prostate Cancer Agents.
January 2016, Anti-cancer agents in medicinal chemistry,
Kun Li, and Ying Li, and Di Zhou, and Yinbo Fan, and Hongye Guo, and Tianyi Ma, and Jiachen Wen, and Dan Liu, and Linxiang Zhao
Development of novel cyanopyridines as PIM-1 kinase inhibitors with potent anti-prostate cancer activity: Synthesis, biological evaluation, nanoparticles formulation and molecular dynamics simulation.
December 2022, Bioorganic chemistry,
Kun Li, and Ying Li, and Di Zhou, and Yinbo Fan, and Hongye Guo, and Tianyi Ma, and Jiachen Wen, and Dan Liu, and Linxiang Zhao
Synthesis and biological evaluation of benzo[d]imidazole derivatives as potential anti-cancer agents.
February 2012, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!